Filana Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $253.9M | $233.4M |
| FY2022 | — | $227.5M | $201.0M |
| FY2023 | — | $137.5M | $121.1M |
| FY2024 | — | $145.7M | $128.6M |
| FY2025 | — | $74.4M | $95.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $253.9M | $233.4M |
| FY2022 | — | $227.5M | $201.0M |
| FY2023 | — | $137.5M | $121.1M |
| FY2024 | — | $145.7M | $128.6M |
| FY2025 | — | $74.4M | $95.5M |